Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-04

FDA Approved: OXAPROZIN — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approves Oxaprozin generic from Amneal Pharmaceuticals NY LLC for the treatment of rheumatoid arthritis and osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxaprozin (Oxaprozin)

Snippet

ORIG AP for OXAPROZIN (OXAPROZIN)